Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 26, 2023
October 25, 2023
b3f969a3-6d17-4b51-aee6-e6cb19f8e4ba
Related Documents
Container Closure Systems for Human Drugs and Biological Products
Guidance DocumentAugust 13, 2026Center for Drug Evaluation and Research
Inspection of Injectable Products for Visible Particulates: Draft Guidance for Industry
Guidance DocumentDecember 16, 2021Center for Drug Evaluation and Research
Postapproval Changes to Drug Substances Guidance for Industry
Guidance DocumentSeptember 11, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.